| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.03e-05 | 20 | 43 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 6.32e-05 | 36 | 43 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.70e-04 | 50 | 43 | 3 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 2.02e-04 | 53 | 43 | 3 | GO:0016859 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 7.03e-07 | 9 | 43 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 7.03e-07 | 9 | 43 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.00e-06 | 10 | 43 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 TXNIP FSIP2 RGPD2 EPS15 RANBP2 LRRC7 NOMO2 NOMO3 NOMO1 PYHIN1 VPS13A | 1.51e-06 | 1091 | 43 | 12 | GO:0033365 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.38e-06 | 13 | 43 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.02e-06 | 14 | 43 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein insertion into membrane | 3.52e-06 | 50 | 43 | 4 | GO:0051205 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 9.39e-06 | 20 | 43 | 3 | GO:0006607 | |
| GeneOntologyBiologicalProcess | lateral mesoderm development | 9.39e-06 | 20 | 43 | 3 | GO:0048368 | |
| GeneOntologyBiologicalProcess | localization within membrane | 3.21e-05 | 798 | 43 | 9 | GO:0051668 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 3.64e-05 | 31 | 43 | 3 | GO:0045048 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 6.77e-05 | 38 | 43 | 3 | GO:0000413 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | 8.59e-05 | 515 | 43 | 7 | GO:0072594 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 8.86e-05 | 7 | 43 | 2 | GO:1900108 | |
| GeneOntologyBiologicalProcess | protein localization to membrane | 9.00e-05 | 705 | 43 | 8 | GO:0072657 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.34e-04 | 1442 | 43 | 11 | GO:0072359 | |
| GeneOntologyBiologicalProcess | regulation of nodal signaling pathway | 1.51e-04 | 9 | 43 | 2 | GO:1900107 | |
| GeneOntologyBiologicalProcess | positive regulation of voltage-gated calcium channel activity | 1.51e-04 | 9 | 43 | 2 | GO:1901387 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to membrane | 1.54e-04 | 130 | 43 | 4 | GO:1905477 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.82e-04 | 405 | 43 | 6 | GO:0033674 | |
| GeneOntologyBiologicalProcess | determination of left/right asymmetry in lateral mesoderm | 1.89e-04 | 10 | 43 | 2 | GO:0003140 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.94e-04 | 54 | 43 | 3 | GO:0018208 | |
| GeneOntologyBiologicalProcess | transition between fast and slow fiber | 3.26e-04 | 13 | 43 | 2 | GO:0014883 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | 3.37e-04 | 1087 | 43 | 9 | GO:0032880 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 3.48e-04 | 161 | 43 | 4 | GO:0051592 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to plasma membrane | 4.19e-04 | 70 | 43 | 3 | GO:1903078 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 4.34e-04 | 1125 | 43 | 9 | GO:0035239 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 4.37e-04 | 71 | 43 | 3 | GO:0006111 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 4.38e-04 | 15 | 43 | 2 | GO:0086069 | |
| GeneOntologyBiologicalProcess | vasodilation | 4.55e-04 | 72 | 43 | 3 | GO:0042311 | |
| GeneOntologyBiologicalProcess | tube development | 4.94e-04 | 1402 | 43 | 10 | GO:0035295 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | 5.04e-04 | 490 | 43 | 6 | GO:0051347 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to membrane | 5.10e-04 | 319 | 43 | 5 | GO:0090150 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA damage response, signal transduction by p53 class mediator | 5.66e-04 | 17 | 43 | 2 | GO:0043517 | |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | RGPD4 RGPD2 STAC2 RANBP2 FBN1 TEAD1 RALGAPA2 EGFR STAC3 PYHIN1 | 5.77e-04 | 1430 | 43 | 10 | GO:0044093 |
| GeneOntologyBiologicalProcess | Golgi to endosome transport | 6.36e-04 | 18 | 43 | 2 | GO:0006895 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to cell periphery | 6.66e-04 | 82 | 43 | 3 | GO:1904377 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 7.16e-04 | 195 | 43 | 4 | GO:0006606 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | 7.45e-04 | 1212 | 43 | 9 | GO:0060341 | |
| GeneOntologyBiologicalProcess | intracellular protein transport | 7.77e-04 | 740 | 43 | 7 | GO:0006886 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 7.88e-04 | 20 | 43 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle adaptation | 7.88e-04 | 20 | 43 | 2 | GO:0014733 | |
| GeneOntologyBiologicalProcess | import into nucleus | 8.02e-04 | 201 | 43 | 4 | GO:0051170 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 8.46e-04 | 89 | 43 | 3 | GO:0060411 | |
| GeneOntologyBiologicalProcess | negative regulation of activin receptor signaling pathway | 8.69e-04 | 21 | 43 | 2 | GO:0032926 | |
| GeneOntologyBiologicalProcess | heart development | 8.88e-04 | 757 | 43 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | muscle system process | 8.96e-04 | 547 | 43 | 6 | GO:0003012 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 9.02e-04 | 362 | 43 | 5 | GO:0034504 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 1.02e-03 | 372 | 43 | 5 | GO:0060485 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by circulatory renin-angiotensin | 1.04e-03 | 23 | 43 | 2 | GO:0001991 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.07e-03 | 217 | 43 | 4 | GO:0006941 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.08e-03 | 218 | 43 | 4 | GO:0090101 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 1.14e-03 | 24 | 43 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | nodal signaling pathway | 1.34e-03 | 26 | 43 | 2 | GO:0038092 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum organization | 1.44e-03 | 107 | 43 | 3 | GO:0007029 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to membrane | 1.48e-03 | 237 | 43 | 4 | GO:1905475 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.60e-03 | 111 | 43 | 3 | GO:0006094 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 1.64e-03 | 244 | 43 | 4 | GO:0006006 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 1.77e-03 | 115 | 43 | 3 | GO:0019319 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 1.78e-03 | 30 | 43 | 2 | GO:0098901 | |
| GeneOntologyBiologicalProcess | regulation of activin receptor signaling pathway | 2.02e-03 | 32 | 43 | 2 | GO:0032925 | |
| GeneOntologyBiologicalProcess | skeletal muscle adaptation | 2.02e-03 | 32 | 43 | 2 | GO:0043501 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 2.05e-03 | 121 | 43 | 3 | GO:0046364 | |
| GeneOntologyBiologicalProcess | blood circulation | 2.13e-03 | 648 | 43 | 6 | GO:0008015 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 4.51e-07 | 8 | 43 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 6.75e-07 | 9 | 43 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.63e-07 | 10 | 43 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | inclusion body | 1.12e-06 | 90 | 43 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.90e-06 | 14 | 43 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.90e-06 | 14 | 43 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 6.47e-06 | 18 | 43 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 9.02e-06 | 20 | 43 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.05e-05 | 21 | 43 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 1.17e-03 | 101 | 43 | 3 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 1.29e-03 | 1327 | 43 | 9 | GO:0042175 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.84e-03 | 431 | 43 | 5 | GO:0031253 | |
| MousePheno | increased hepatocellular carcinoma incidence | 7.87e-07 | 70 | 35 | 5 | MP:0003331 | |
| MousePheno | long snout | 6.09e-06 | 2 | 35 | 2 | MP:0000446 | |
| MousePheno | increased hepatobiliary system tumor incidence | 7.74e-06 | 111 | 35 | 5 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 7.74e-06 | 111 | 35 | 5 | MP:0008019 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 7.87e-06 | 16 | 35 | 3 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 3.59e-05 | 26 | 35 | 3 | MP:0012058 | |
| MousePheno | cardiac valve regurgitation | 3.59e-05 | 26 | 35 | 3 | MP:0009384 | |
| MousePheno | increased lung carcinoma incidence | 4.12e-05 | 78 | 35 | 4 | MP:0008714 | |
| MousePheno | abnormal heart valve physiology | 5.57e-05 | 30 | 35 | 3 | MP:0011926 | |
| MousePheno | decreased tumor latency | 5.57e-05 | 30 | 35 | 3 | MP:0010308 | |
| MousePheno | absent cochlear ganglion | 6.06e-05 | 5 | 35 | 2 | MP:0003146 | |
| MousePheno | failure of blastocyst formation | 6.16e-05 | 31 | 35 | 3 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 8.16e-05 | 34 | 35 | 3 | MP:0010307 | |
| MousePheno | enlarged epididymis | 1.05e-04 | 99 | 35 | 4 | MP:0004931 | |
| MousePheno | abnormal heart ventricle morphology | 1.08e-04 | 793 | 35 | 9 | MP:0005294 | |
| MousePheno | abnormal susceptibility to hearing loss | 1.14e-04 | 38 | 35 | 3 | MP:0006334 | |
| MousePheno | increased sarcoma incidence | 1.18e-04 | 102 | 35 | 4 | MP:0002032 | |
| MousePheno | increased carcinoma incidence | 1.22e-04 | 197 | 35 | 5 | MP:0002038 | |
| MousePheno | abnormal blastocyst formation | 1.24e-04 | 39 | 35 | 3 | MP:0012128 | |
| MousePheno | abnormal costal cartilage morphology | 1.27e-04 | 7 | 35 | 2 | MP:0006432 | |
| MousePheno | increased respiratory system tumor incidence | 1.42e-04 | 107 | 35 | 4 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 1.42e-04 | 107 | 35 | 4 | MP:0008014 | |
| MousePheno | abnormal mitral valve morphology | 1.44e-04 | 41 | 35 | 3 | MP:0000286 | |
| MousePheno | abnormal sensory ganglion morphology | 2.08e-04 | 221 | 35 | 5 | MP:0000960 | |
| MousePheno | absent posterior semicircular canal | 2.17e-04 | 9 | 35 | 2 | MP:0003163 | |
| MousePheno | abnormal aorta morphology | 2.26e-04 | 225 | 35 | 5 | MP:0000272 | |
| MousePheno | increased malignant tumor incidence | 2.88e-04 | 237 | 35 | 5 | MP:0002018 | |
| MousePheno | abnormal common crus morphology | 3.30e-04 | 11 | 35 | 2 | MP:0004922 | |
| MousePheno | fusion of glossopharyngeal and vagus nerve | 3.30e-04 | 11 | 35 | 2 | MP:0004568 | |
| MousePheno | abnormal thoracic aorta morphology | 3.36e-04 | 134 | 35 | 4 | MP:0010468 | |
| MousePheno | increased organ/body region tumor incidence | 3.97e-04 | 395 | 35 | 6 | MP:0010274 | |
| MousePheno | increased incidence of tumors by chemical induction | 4.07e-04 | 141 | 35 | 4 | MP:0004499 | |
| MousePheno | abnormal organ/body region tumor incidence | 4.30e-04 | 401 | 35 | 6 | MP:0013152 | |
| MousePheno | abnormal pulmonary alveolar duct morphology | 4.67e-04 | 13 | 35 | 2 | MP:0002271 | |
| MousePheno | absent lateral semicircular canal | 4.67e-04 | 13 | 35 | 2 | MP:0003161 | |
| MousePheno | aneuploidy | 4.68e-04 | 61 | 35 | 3 | MP:0004024 | |
| MousePheno | abnormal lung morphology | 4.96e-04 | 767 | 35 | 8 | MP:0001175 | |
| MousePheno | small otic vesicle | 6.27e-04 | 15 | 35 | 2 | MP:0004310 | |
| MousePheno | abnormal mitral valve cusp morphology | 6.27e-04 | 15 | 35 | 2 | MP:0010614 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 6.56e-04 | 160 | 35 | 4 | MP:0005659 | |
| MousePheno | abnormal atrioventricular valve morphology | 6.73e-04 | 69 | 35 | 3 | MP:0002745 | |
| MousePheno | abnormal heart valve morphology | 7.04e-04 | 163 | 35 | 4 | MP:0000285 | |
| MousePheno | abnormal superior semicircular canal morphology | 7.15e-04 | 16 | 35 | 2 | MP:0003069 | |
| MousePheno | disorganized pancreatic islets | 7.15e-04 | 16 | 35 | 2 | MP:0009254 | |
| MousePheno | interrupted aortic arch, type b | 7.15e-04 | 16 | 35 | 2 | MP:0011659 | |
| MousePheno | abnormal respiratory system morphology | 7.42e-04 | 1027 | 35 | 9 | MP:0002132 | |
| MousePheno | abnormal epididymis size | 7.54e-04 | 166 | 35 | 4 | MP:0004926 | |
| MousePheno | small middle ear ossicles | 8.09e-04 | 17 | 35 | 2 | MP:0030123 | |
| MousePheno | abnormal fourth pharyngeal arch artery morphology | 8.09e-04 | 17 | 35 | 2 | MP:0006354 | |
| MousePheno | abnormal heart atrium and ventricle connection | 8.58e-04 | 75 | 35 | 3 | MP:0010435 | |
| MousePheno | increased incidence of induced tumors | 8.79e-04 | 173 | 35 | 4 | MP:0002021 | |
| MousePheno | abnormal atrioventricular cushion morphology | 8.92e-04 | 76 | 35 | 3 | MP:0000297 | |
| MousePheno | abnormal systemic artery morphology | 8.94e-04 | 304 | 35 | 5 | MP:0011655 | |
| MousePheno | semilunar valve regurgitation | 9.09e-04 | 18 | 35 | 2 | MP:0006049 | |
| MousePheno | decreased atrioventricular cushion size | 9.09e-04 | 18 | 35 | 2 | MP:0000301 | |
| MousePheno | abnormal cranial ganglia morphology | 9.18e-04 | 175 | 35 | 4 | MP:0001081 | |
| MousePheno | abnormal ear morphology | 9.91e-04 | 470 | 35 | 6 | MP:0002102 | |
| MousePheno | abnormal fetal atrioventricular canal morphology | 1.07e-03 | 81 | 35 | 3 | MP:0006107 | |
| MousePheno | abnormal posterior semicircular canal morphology | 1.12e-03 | 20 | 35 | 2 | MP:0002858 | |
| MousePheno | decreased susceptibility to weight gain | 1.15e-03 | 186 | 35 | 4 | MP:0010182 | |
| MousePheno | decreased cornea thickness | 1.24e-03 | 21 | 35 | 2 | MP:0005543 | |
| MousePheno | abnormal lateral semicircular canal morphology | 1.24e-03 | 21 | 35 | 2 | MP:0000037 | |
| MousePheno | abnormal otic capsule morphology | 1.24e-03 | 21 | 35 | 2 | MP:0000039 | |
| MousePheno | abnormal chromosome number | 1.28e-03 | 86 | 35 | 3 | MP:0004023 | |
| MousePheno | abnormal innervation | 1.32e-03 | 193 | 35 | 4 | MP:0002184 | |
| MousePheno | abnormal glossopharyngeal nerve morphology | 1.36e-03 | 22 | 35 | 2 | MP:0001073 | |
| MousePheno | abnormal cochlear ganglion morphology | 1.36e-03 | 88 | 35 | 3 | MP:0002855 | |
| MousePheno | cardiac hypertrophy | 1.40e-03 | 196 | 35 | 4 | MP:0001625 | |
| MousePheno | increased energy expenditure | 1.40e-03 | 196 | 35 | 4 | MP:0004889 | |
| MousePheno | abnormal fourth pharyngeal arch morphology | 1.49e-03 | 23 | 35 | 2 | MP:0006340 | |
| MousePheno | abnormal P wave | 1.62e-03 | 24 | 35 | 2 | MP:0004070 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 1.71e-03 | 207 | 35 | 4 | MP:0003308 | |
| MousePheno | abnormal cerebellum development | 1.75e-03 | 96 | 35 | 3 | MP:0000854 | |
| MousePheno | abnormal maternal decidual layer morphology | 1.76e-03 | 25 | 35 | 2 | MP:0004256 | |
| MousePheno | embryonic lethality between implantation and somite formation, incomplete penetrance | 1.76e-03 | 25 | 35 | 2 | MP:0011106 | |
| MousePheno | abnormal organ of Corti morphology | 1.77e-03 | 209 | 35 | 4 | MP:0000042 | |
| MousePheno | increased tumor incidence | 1.84e-03 | 530 | 35 | 6 | MP:0002020 | |
| MousePheno | primary atelectasis | 2.06e-03 | 27 | 35 | 2 | MP:0010819 | |
| MousePheno | abnormal heart left ventricle morphology | 2.11e-03 | 369 | 35 | 5 | MP:0003921 | |
| MousePheno | abnormal crista ampullaris morphology | 2.21e-03 | 28 | 35 | 2 | MP:0004249 | |
| MousePheno | abnormal cochlear outer hair cell physiology | 2.21e-03 | 28 | 35 | 2 | MP:0004434 | |
| MousePheno | abnormal vagus nerve morphology | 2.37e-03 | 29 | 35 | 2 | MP:0001074 | |
| MousePheno | decreased heart ventricle muscle contractility | 2.39e-03 | 107 | 35 | 3 | MP:0005598 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 2.39e-03 | 107 | 35 | 3 | MP:0003694 | |
| MousePheno | increased classified tumor incidence | 2.43e-03 | 381 | 35 | 5 | MP:0010273 | |
| MousePheno | abnormal eye electrophysiology | 2.43e-03 | 228 | 35 | 4 | MP:0005551 | |
| MousePheno | atelectasis | 2.45e-03 | 108 | 35 | 3 | MP:0001177 | |
| Domain | DUF2012 | 4.54e-08 | 4 | 43 | 3 | PF09430 | |
| Domain | DUF2012 | 4.54e-08 | 4 | 43 | 3 | IPR019008 | |
| Domain | Carb-bd-like_fold | 6.31e-07 | 8 | 43 | 3 | IPR013784 | |
| Domain | Ran_BP1 | 2.46e-06 | 12 | 43 | 3 | PF00638 | |
| Domain | RANBD1 | 2.46e-06 | 12 | 43 | 3 | PS50196 | |
| Domain | CarboxyPept_regulatory_dom | 3.20e-06 | 13 | 43 | 3 | IPR014766 | |
| Domain | - | 3.20e-06 | 13 | 43 | 3 | 2.60.40.1120 | |
| Domain | RanBD | 3.20e-06 | 13 | 43 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 3.20e-06 | 13 | 43 | 3 | IPR000156 | |
| Domain | CarboxyPept-like_regulatory | 7.56e-06 | 17 | 43 | 3 | IPR008969 | |
| Domain | GCC2_Rab_bind | 1.08e-04 | 7 | 43 | 2 | IPR032023 | |
| Domain | Rab_bind | 1.08e-04 | 7 | 43 | 2 | PF16704 | |
| Domain | - | 2.30e-04 | 10 | 43 | 2 | 1.10.220.60 | |
| Domain | Grip | 2.81e-04 | 11 | 43 | 2 | SM00755 | |
| Domain | GRIP | 2.81e-04 | 11 | 43 | 2 | PF01465 | |
| Domain | GRIP_dom | 3.37e-04 | 12 | 43 | 2 | IPR000237 | |
| Domain | GRIP | 3.37e-04 | 12 | 43 | 2 | PS50913 | |
| Domain | TPR-contain_dom | 3.87e-04 | 150 | 43 | 4 | IPR013026 | |
| Domain | TPR_REGION | 5.54e-04 | 165 | 43 | 4 | PS50293 | |
| Domain | TPR | 5.54e-04 | 165 | 43 | 4 | PS50005 | |
| Domain | TPR | 3.25e-03 | 129 | 43 | 3 | SM00028 | |
| Domain | TPR_repeat | 3.54e-03 | 133 | 43 | 3 | IPR019734 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 9.31e-06 | 18 | 33 | 3 | MM1549 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 4.10e-05 | 29 | 33 | 3 | M29808 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.09e-04 | 40 | 33 | 3 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.17e-04 | 41 | 33 | 3 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 1.26e-04 | 42 | 33 | 3 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.35e-04 | 43 | 33 | 3 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.77e-04 | 47 | 33 | 3 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.00e-04 | 49 | 33 | 3 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.13e-04 | 50 | 33 | 3 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.25e-04 | 51 | 33 | 3 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.82e-04 | 55 | 33 | 3 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 3.30e-04 | 58 | 33 | 3 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.30e-04 | 58 | 33 | 3 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 4.62e-04 | 65 | 33 | 3 | MM15147 | |
| Pathway | REACTOME_SUMOYLATION | 6.22e-04 | 169 | 33 | 4 | MM14919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 6.25e-04 | 16 | 33 | 2 | M47449 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.50e-04 | 73 | 33 | 3 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 9.13e-04 | 82 | 33 | 3 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 9.79e-04 | 84 | 33 | 3 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.05e-03 | 86 | 33 | 3 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.27e-03 | 92 | 33 | 3 | MM14951 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 1.76e-09 | 3 | 43 | 3 | 25576386 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 32377695 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 7.04e-09 | 4 | 43 | 3 | 31833031 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 9267806 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 9037092 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 6.14e-08 | 7 | 43 | 3 | 11353387 | |
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 30944974 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 6.14e-08 | 7 | 43 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 6.14e-08 | 7 | 43 | 3 | 17372272 | |
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 38657106 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 21205196 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 18949001 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 25187515 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 8603673 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 26632511 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 24403063 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 23818861 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 23536549 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 12191015 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 22821000 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 9.82e-08 | 8 | 43 | 3 | 21670213 | |
| Pubmed | 9.82e-08 | 8 | 43 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 9.82e-08 | 8 | 43 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 9.82e-08 | 8 | 43 | 3 | 22262462 | |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 9.82e-08 | 8 | 43 | 3 | 15257293 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 9.82e-08 | 8 | 43 | 3 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 1.47e-07 | 9 | 43 | 3 | 18394993 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 28100513 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 17887960 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 11553612 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 10601307 | ||
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 1.47e-07 | 9 | 43 | 3 | 36261522 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 9733766 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 28877029 | ||
| Pubmed | 2.10e-07 | 10 | 43 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 2.10e-07 | 10 | 43 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 2.10e-07 | 10 | 43 | 3 | 8857542 | |
| Pubmed | 2.10e-07 | 10 | 43 | 3 | 21859863 | ||
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.88e-07 | 11 | 43 | 3 | 35771867 | |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 2.88e-07 | 11 | 43 | 3 | 32820719 | |
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 4.99e-07 | 13 | 43 | 3 | 31427429 | |
| Pubmed | 6.88e-07 | 606 | 43 | 8 | 36538041 | ||
| Pubmed | 7.93e-07 | 15 | 43 | 3 | 14697343 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 33323975 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 26918609 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 21832070 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 18987342 | ||
| Pubmed | 2.67e-06 | 22 | 43 | 3 | 27717094 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 25623042 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 21226813 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 30417565 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 32356386 | ||
| Pubmed | USP9X Controls EGFR Fate by Deubiquitinating the Endocytic Adaptor Eps15. | 4.48e-06 | 3 | 43 | 2 | 26748853 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 15383614 | ||
| Pubmed | Fibrillin-1 directly regulates osteoclast formation and function by a dual mechanism. | 4.48e-06 | 3 | 43 | 2 | 24039232 | |
| Pubmed | TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer. | 4.48e-06 | 3 | 43 | 2 | 25605021 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 27859049 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 15465819 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 15701692 | ||
| Pubmed | 5.78e-06 | 568 | 43 | 7 | 37774976 | ||
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 7.72e-06 | 31 | 43 | 3 | 19136429 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 10953014 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 17227756 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 29467163 | ||
| Pubmed | Association and colocalization of Eps15 with adaptor protein-2 and clathrin. | 8.94e-06 | 4 | 43 | 2 | 9049247 | |
| Pubmed | 9.36e-06 | 33 | 43 | 3 | 30783098 | ||
| Pubmed | 1.22e-05 | 418 | 43 | 6 | 34709266 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.44e-05 | 38 | 43 | 3 | 12791264 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 19109251 | ||
| Pubmed | Loss of connexin45 causes a cushion defect in early cardiogenesis. | 1.49e-05 | 5 | 43 | 2 | 10903175 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.65e-05 | 123 | 43 | 4 | 26912792 | |
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 23818578 | ||
| Pubmed | 2.23e-05 | 6 | 43 | 2 | 24196714 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 3.12e-05 | 7 | 43 | 2 | 15710750 | |
| Pubmed | Endothelial deletion of PTBP1 disrupts ventricular chamber development. | 3.12e-05 | 7 | 43 | 2 | 37002228 | |
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 24368733 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.24e-05 | 146 | 43 | 4 | 23892456 | |
| Pubmed | Single-cell analysis of early progenitor cells that build coronary arteries. | 4.16e-05 | 8 | 43 | 2 | 29973725 | |
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 16862145 | ||
| Pubmed | 4.16e-05 | 8 | 43 | 2 | 26176759 | ||
| Pubmed | NFATC1 promotes epicardium-derived cell invasion into myocardium. | 4.16e-05 | 8 | 43 | 2 | 21447555 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 5.31e-05 | 544 | 43 | 6 | 28473536 | |
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 23222715 | ||
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 15850572 | ||
| Pubmed | HIV-1 evades innate immune recognition through specific cofactor recruitment. | 5.35e-05 | 9 | 43 | 2 | 24196705 | |
| Pubmed | 5.35e-05 | 9 | 43 | 2 | 19289468 | ||
| Pubmed | 5.42e-05 | 331 | 43 | 5 | 20634891 | ||
| Pubmed | USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification. | 6.33e-05 | 62 | 43 | 3 | 31340145 | |
| Pubmed | 6.64e-05 | 63 | 43 | 3 | 31266804 | ||
| Pubmed | Regulation of ubiquitin-binding proteins by monoubiquitination. | 6.68e-05 | 10 | 43 | 2 | 16429130 | |
| Pubmed | Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation. | 8.15e-05 | 11 | 43 | 2 | 15962011 | |
| Pubmed | CHD7 interacts with BMP R-SMADs to epigenetically regulate cardiogenesis in mice. | 8.15e-05 | 11 | 43 | 2 | 24293546 | |
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 28165338 | ||
| Pubmed | Endocardium Minimally Contributes to Coronary Endothelium in the Embryonic Ventricular Free Walls. | 8.15e-05 | 11 | 43 | 2 | 27056912 | |
| Pubmed | 8.15e-05 | 11 | 43 | 2 | 31444215 | ||
| Interaction | RGPD4 interactions | 1.35e-05 | 22 | 43 | 3 | int:RGPD4 | |
| Interaction | RGPD8 interactions | 1.85e-05 | 74 | 43 | 4 | int:RGPD8 | |
| Interaction | RGPD2 interactions | 2.55e-05 | 27 | 43 | 3 | int:RGPD2 | |
| Interaction | NCLN interactions | 4.25e-05 | 183 | 43 | 5 | int:NCLN | |
| Interaction | CLEC16A interactions | 4.75e-05 | 629 | 43 | 8 | int:CLEC16A | |
| Cytoband | 2q12.3 | 1.21e-04 | 17 | 44 | 2 | 2q12.3 | |
| Cytoband | 1q21.1 | 1.64e-03 | 62 | 44 | 2 | 1q21.1 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.86e-04 | 115 | 26 | 3 | 769 | |
| GeneFamily | PDZ domain containing | 2.00e-02 | 152 | 26 | 2 | 1220 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 1.30e-05 | 474 | 44 | 7 | M40991 | |
| Coexpression | RAF_UP.V1_UP | 1.77e-05 | 193 | 44 | 5 | M2728 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 2.22e-05 | 98 | 44 | 4 | MM942 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.32e-05 | 33 | 44 | 3 | MM477 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 2.53e-05 | 208 | 44 | 5 | M39139 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 5.20e-05 | 43 | 44 | 3 | MM3857 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 6.12e-05 | 1074 | 44 | 9 | M1941 | |
| Coexpression | GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN | 8.24e-05 | 137 | 44 | 4 | M417 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP | 8.24e-05 | 137 | 44 | 4 | M34024 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.18e-05 | 261 | 42 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 2.07e-05 | 82 | 42 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 5.34e-05 | 37 | 42 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 8.17e-05 | 734 | 42 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 8.42e-05 | 371 | 42 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 1.15e-04 | 127 | 42 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.25e-04 | 130 | 42 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.96e-04 | 146 | 42 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 2.01e-04 | 147 | 42 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 2.17e-04 | 59 | 42 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#1_top-relative-expression-ranked_500 | 2.39e-04 | 61 | 42 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 2.52e-04 | 156 | 42 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.89e-04 | 65 | 42 | 3 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 3.13e-04 | 165 | 42 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 3.20e-04 | 166 | 42 | 4 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_100 | 4.06e-04 | 73 | 42 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.54e-04 | 328 | 42 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100 | 4.58e-04 | 76 | 42 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#1_top-relative-expression-ranked_200 | 5.10e-04 | 17 | 42 | 2 | gudmap_kidney_e10.5_UretericTip_HoxB7_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.44e-04 | 191 | 42 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 5.56e-04 | 973 | 42 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 5.56e-04 | 973 | 42 | 8 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.44e-08 | 192 | 44 | 6 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.24e-06 | 191 | 44 | 5 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-06 | 198 | 44 | 5 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 1.52e-06 | 199 | 44 | 5 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 1.52e-06 | 199 | 44 | 5 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.82e-06 | 119 | 44 | 4 | 8eefcf1ace62ad1c90fa5b62ec159c83ec527bf3 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-05 | 150 | 44 | 4 | b30f52b94ce772632a1f2f5e0837db876cf92651 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-05 | 150 | 44 | 4 | 05b9a9cbc5a95cdaf45d5f173e132acd4da9aa8a | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 169 | 44 | 4 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 175 | 44 | 4 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 175 | 44 | 4 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 178 | 44 | 4 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 178 | 44 | 4 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-05 | 179 | 44 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.03e-05 | 181 | 44 | 4 | 9b2d207dc9fc2228a1555ed360286bb7c2d988ff | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 3.44e-05 | 187 | 44 | 4 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.44e-05 | 187 | 44 | 4 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 3.44e-05 | 187 | 44 | 4 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.59e-05 | 189 | 44 | 4 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 190 | 44 | 4 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 190 | 44 | 4 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.74e-05 | 191 | 44 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.82e-05 | 192 | 44 | 4 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.82e-05 | 192 | 44 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 193 | 44 | 4 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 193 | 44 | 4 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 3.90e-05 | 193 | 44 | 4 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 193 | 44 | 4 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 3.90e-05 | 193 | 44 | 4 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 193 | 44 | 4 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-05 | 194 | 44 | 4 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.98e-05 | 194 | 44 | 4 | 638b9fdce64ed00243b5303800ec66207d5fd640 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.98e-05 | 194 | 44 | 4 | e9868c22934b6c0ac35e3e8270ec0b671bc6582a | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.98e-05 | 194 | 44 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 3.98e-05 | 194 | 44 | 4 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.98e-05 | 194 | 44 | 4 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.98e-05 | 194 | 44 | 4 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.98e-05 | 194 | 44 | 4 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 3.98e-05 | 194 | 44 | 4 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.98e-05 | 194 | 44 | 4 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-05 | 195 | 44 | 4 | 0feb6ebe7b4b781dec7cfaef844140cfbf84b4b9 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-05 | 195 | 44 | 4 | 2a6f67875cef140b0e6b8401436719675c6b3665 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-05 | 195 | 44 | 4 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 4.06e-05 | 195 | 44 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 4.14e-05 | 196 | 44 | 4 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.22e-05 | 197 | 44 | 4 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.22e-05 | 197 | 44 | 4 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.22e-05 | 197 | 44 | 4 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.30e-05 | 198 | 44 | 4 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.39e-05 | 199 | 44 | 4 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-05 | 200 | 44 | 4 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-05 | 200 | 44 | 4 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.38e-04 | 122 | 44 | 3 | 2880f25d10a7765e55a2aa20c7a6ef74cea19c4d | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.38e-04 | 122 | 44 | 3 | ecd0e54dd829201290212ea2ff7c8e7eec19c0e9 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.38e-04 | 122 | 44 | 3 | cffd7730bda90828efc0def452cabb44cf93ab48 | |
| ToppCell | Posterior_cortex-Macroglia-OLIGODENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.49e-04 | 124 | 44 | 3 | 9f169fa17be1842a6bd83778ff30465a740edd5f | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.80e-04 | 129 | 44 | 3 | b3cb0c10659d1216b8f7de3aa1f9aac101cb65dd | |
| ToppCell | TCGA-Bone_and_Soft_Tissue|World / Sample_Type by Project: Shred V9 | 3.13e-04 | 134 | 44 | 3 | 9940a710a5d6670244cce5e19f88b4195a59875b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.27e-04 | 136 | 44 | 3 | 8f5682422ba0b477c1e0700212948457f106cb10 | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.34e-04 | 137 | 44 | 3 | ca8fdbe66a854e6283b22179ec9359ea9e86cd8e | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.34e-04 | 137 | 44 | 3 | 5e97480f014f1d9267e8126f1d0e58acd22f36aa | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.48e-04 | 139 | 44 | 3 | 789edd3c98e7c5c1cc402c780fded9a9dfd1dfb8 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.56e-04 | 140 | 44 | 3 | eb1d22f5f5dbf60b6485464baec4be9b3060f65c | |
| ToppCell | tumor_Lung-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 3.63e-04 | 141 | 44 | 3 | f62d78b3f998f3ea493647c4c5b86cfec2243f0b | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.78e-04 | 143 | 44 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-04 | 144 | 44 | 3 | f6061dd965a2b2fe6ad864f8aecc06d2e74881ce | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.94e-04 | 145 | 44 | 3 | ffbdadea0185e5d3b85f2868d5ec82b50cf2e2a1 | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.18e-04 | 148 | 44 | 3 | 44128692824ca419fface0af41099c17135933ce | |
| ToppCell | primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.18e-04 | 148 | 44 | 3 | d60f93311cfa718d026a0dbf61771bbbcbb79146 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.27e-04 | 149 | 44 | 3 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-04 | 149 | 44 | 3 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.27e-04 | 149 | 44 | 3 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.27e-04 | 149 | 44 | 3 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | metastatic_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 4.70e-04 | 154 | 44 | 3 | 423f58fc7dcef068458cbf7b4ee989e37227041e | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 154 | 44 | 3 | 37765512dfae557b9f6eb30a29463b93682a4404 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 155 | 44 | 3 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-04 | 155 | 44 | 3 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-04 | 155 | 44 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.88e-04 | 156 | 44 | 3 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-04 | 157 | 44 | 3 | 74038192f016f95f80e0189035ee8ccc22ceb1b8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.97e-04 | 157 | 44 | 3 | 982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 5.16e-04 | 159 | 44 | 3 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.16e-04 | 159 | 44 | 3 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-04 | 160 | 44 | 3 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-04 | 160 | 44 | 3 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.25e-04 | 160 | 44 | 3 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 5.35e-04 | 161 | 44 | 3 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 5.74e-04 | 165 | 44 | 3 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.95e-04 | 167 | 44 | 3 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.95e-04 | 167 | 44 | 3 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.05e-04 | 168 | 44 | 3 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 6.05e-04 | 168 | 44 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-04 | 168 | 44 | 3 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.16e-04 | 169 | 44 | 3 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | severe_influenza-gd_T|World / disease group, cell group and cell class (v2) | 6.16e-04 | 169 | 44 | 3 | 6d514dd2d1e5253bce49279f43aa2fa2b7c2653e | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 6.16e-04 | 169 | 44 | 3 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.16e-04 | 169 | 44 | 3 | bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.26e-04 | 170 | 44 | 3 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 6.26e-04 | 170 | 44 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-04 | 171 | 44 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| Disease | brain disease (is_implicated_in) | 1.36e-04 | 12 | 43 | 2 | DOID:936 (is_implicated_in) | |
| Disease | maximum cigarettes per day measurement | 3.13e-04 | 18 | 43 | 2 | EFO_0009264 | |
| Disease | hypertension (biomarker_via_orthology) | 3.33e-04 | 227 | 43 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 3.49e-04 | 19 | 43 | 2 | DOID:2876 (is_marker_for) | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 3.88e-04 | 20 | 43 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Head Neoplasms | 5.61e-04 | 24 | 43 | 2 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 5.61e-04 | 24 | 43 | 2 | C0887900 | |
| Disease | Cancer of Head | 5.61e-04 | 24 | 43 | 2 | C0751177 | |
| Disease | Neck Neoplasms | 6.09e-04 | 25 | 43 | 2 | C0027533 | |
| Disease | Cancer of Neck | 6.09e-04 | 25 | 43 | 2 | C0746787 | |
| Disease | Endogenous Hyperinsulinism | 6.59e-04 | 26 | 43 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 6.59e-04 | 26 | 43 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 6.59e-04 | 26 | 43 | 2 | C1257965 | |
| Disease | hypertension, COVID-19 | 7.11e-04 | 27 | 43 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | Hyperinsulinism | 7.65e-04 | 28 | 43 | 2 | C0020459 | |
| Disease | thoracic aortic aneurysm | 8.79e-04 | 30 | 43 | 2 | EFO_0004282 | |
| Disease | Hyperglycemia, Postprandial | 8.79e-04 | 30 | 43 | 2 | C1855520 | |
| Disease | Hyperglycemia | 8.79e-04 | 30 | 43 | 2 | C0020456 | |
| Disease | hypertension | 1.03e-03 | 307 | 43 | 4 | EFO_0000537 | |
| Disease | Head and Neck Neoplasms | 1.06e-03 | 33 | 43 | 2 | C0018671 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGGGFEPNFMLFEKC | 101 | P07203 | |
| FPKRFQIVLFDPKGG | 5591 | Q8WXG9 | |
| KVGVFNNKGEGPFSP | 776 | Q8IWV2 | |
| AFKGEAGGLLVFPPA | 496 | O14529 | |
| PSKGFGKDDFPGGVD | 611 | Q9P2D1 | |
| PKAFHAGKLFPFGGT | 1046 | Q9HCE9 | |
| FGKKDPNFKGFSGAG | 1961 | P49792 | |
| QPGGKFAFFKVLPGD | 166 | P69849 | |
| GKGITEPPFGIFVFN | 91 | Q14126 | |
| QPGGKFAFFKVLPGD | 166 | Q5JPE7 | |
| SGQGNPFKPSDKGIF | 1466 | Q96NW7 | |
| GPDGKGKLDFPEGVF | 636 | Q14526 | |
| QLFGGDIKDGGLFPP | 91 | Q8IYA8 | |
| VFRPDKGNQFPGGKV | 5846 | Q5CZC0 | |
| KAKLFIGFGFPYEGP | 526 | Q3V5L5 | |
| DNPIFEKFGKGGTYP | 251 | Q9Y2U5 | |
| KFPLGPAAAVFGRGE | 11 | O95644 | |
| QPGGKFAFFKVLPGD | 166 | Q15155 | |
| NFDFPFKKGSGIPLL | 236 | Q9UQ07 | |
| FFAKYPQAGAGEKPR | 911 | Q07075 | |
| KKPEVPFFGPLFDGA | 1786 | Q2PPJ7 | |
| PFFGPLFDGAIVSGK | 1791 | Q2PPJ7 | |
| FFPKEAKPNGIFKGS | 1176 | P00533 | |
| KFAPQPLPGGGNFDK | 126 | P52951 | |
| GPGFATKEITNGKPF | 1011 | P35555 | |
| LENGPGGKFFNPFSN | 271 | P36382 | |
| FPGDAGLGKLIEFFK | 56 | Q6K0P9 | |
| GQGKYEPGFFPKLQS | 661 | Q6IQ26 | |
| QFPKFNFVGKLLGPR | 66 | O75525 | |
| FGKIDPFGGDPFKGS | 636 | P42566 | |
| VPKDKEGGVFDLGPF | 311 | Q14653 | |
| FGKKDPNFKGFSGAG | 986 | Q7Z3J3 | |
| FQFGKKDPNFKGFSG | 976 | P0DJD1 | |
| PDAIGGGAKQPKAVF | 61 | Q8WU76 | |
| LEFKPFSNGPLVGGF | 481 | Q96QV1 | |
| PVGGICGQKQKPSFF | 31 | Q96LM1 | |
| GGVFTDPKQIFKSPG | 136 | P98066 | |
| KPIKGAQKGGAAGFF | 2981 | Q96RL7 | |
| AVPFGKIVGKFPGQI | 186 | Q9BVS5 | |
| KGKIGDRVGFFPANF | 331 | Q6ZMT1 | |
| FKGPRFALPKFGVRG | 1016 | Q9BXM0 | |
| GFGMIGPKDFFPLLD | 311 | Q6NUQ4 | |
| GGLKELFGKGPQNAF | 271 | P28347 | |
| FGFELPQGPLGTSFK | 101 | Q9H3M7 | |
| RGKIGEKVGFFPPNF | 286 | Q96MF2 |